Partner Dan Shores will present on "An Overview of the LNP IP Field - Where Are We Now?" at the 3rd Annual LNP Formulation & Process Development Summit taking place April 29-May 4, 2024, in Boston, Massachusetts. Dan's session will be held on Thursday, May 4, during the Post-Conference Day.
Dan's session will spotlight the properties of LNP that create unique IP challenges; review the breadth of LNP development from discovery to manufacturing to understand hotspots for IP bottlenecks; and suggest future strategy to enable the LNP field to progress with collaborative discussion without the compromise of IP.
The 3rd LNP Formulation & Process Development Summit will bring together over 400 experts in LNP Biology, Chemistry, Formulation, Analytical Development, Process Development, Manufacturing and more. Join the ever-growing community of LNP pioneers as they tackle the challenges associated with developing safe, compliant and efficacious LNPs, to treat a variety of disease indications at a variety of target organs. This starts with the in vitro discovery of LNPs through to the manufacturing processes, with end-to-end synergy fundamental.
To learn more about the event, and to register, please visit the event website.
